iHuman Inc. Files 6-K Report
Ticker: IH · Form: 6-K · Filed: Dec 26, 2024 · CIK: 1814423
Sentiment: neutral
Topics: sec-filing, 6-K, disclosure
TL;DR
iHuman Inc. dropped a 6-K filing on 12/26/24, check the press release for deets.
AI Summary
iHuman Inc. filed a Form 6-K on December 26, 2024, reporting information for the month of December 2024. The filing includes a press release as Exhibit 99.1. Vivien Weiwei Wang, Director and Chief Financial Officer, signed the report on behalf of the company.
Why It Matters
This filing provides updated information and disclosures from iHuman Inc. to the SEC, which is important for investors to stay informed about the company's current status.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- iHuman Inc. (company) — Registrant
- Vivien Weiwei Wang (person) — Director and Chief Financial Officer
- December 26, 2024 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
Who signed the Form 6-K filing for iHuman Inc.?
The Form 6-K filing was signed by Vivien Weiwei Wang, Director and Chief Financial Officer, on behalf of iHuman Inc.
What exhibit is included with this 6-K filing?
Exhibit 99.1, a Press Release, is included with this 6-K filing.
What is the principal executive office address for iHuman Inc.?
The principal executive offices are located at Building A, No. 1 Wangjing East Road, Chaoyang District, Beijing 100102, People's Republic of China.
What is the SEC file number for iHuman Inc.?
The SEC file number for iHuman Inc. is 001-39591.
Filing Stats: 151 words · 1 min read · ~1 pages · Grade level 10.2 · Accepted 2024-12-26 06:01:05
Filing Documents
- tm2432044d1_6k.htm (6-K) — 10KB
- tm2432044d1_ex99-1.htm (EX-99.1) — 182KB
- tm2432044d1_ex99-1img001.jpg (GRAPHIC) — 2KB
- 0001104659-24-131456.txt ( ) — 196KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. iHuman Inc . By : /s/ Vivien Weiwei Wang Name : Vivien Weiwei Wang Title : Director and Chief Financial Officer Date: December 26, 2024